Pluribus Labs’s Universal Corp UVV Stock Holding History

Pluribus Labs’s Portfolio UVV Stock Details UVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,815	Closed	-$594K	–	211
2021 Q4	$594K	Buy	+10,815	New	+$539K	0.63%	32

Other funds holding UVV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pluribus Labs's UVV Position: Q1 2022 in Review

Pluribus Labs sold out of Universal Corp (UVV) in Q1 2022, closing a stake of 10,815 shares — an estimated $594K sold.

Pluribus Labs first reported a position in UVV in Q4 2021 and held it in 1 quarter. The position peaked at $594K in Q4 2021. 190 funds tracked by Wall St. Rank hold UVV as of Q1 2022.

Pluribus Labs reported no remaining Universal Corp position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 10,815 Universal Corp shares in Q1 2022, an estimated $594K.
Pluribus Labs first reported a position in Universal Corp in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Universal Corp position peaked at $594K in Q4 2021.
190 funds tracked by Wall St. Rank held Universal Corp as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.